Biogen Idec (BIIB)
$225.89
0.51 (0.23%)
BIIB Stock Quote Delayed 30 Minutes
10 Goldman Sachs Top Stock Picks for 2019
Chances are, the volatility of the 2018 markets isn't going anywhere. But Goldman Sachs is here to help with these top stock picks for 2019.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
32.53B
PE Ratio
35.86
EPS
6.3
Volume (Avg. Vol.)
96,738
Day's Range
$223.62 - $228.48
52-Week Range
$189.44 - $280.41
Dividend & Yield
N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen Idec News
Biogen Earnings: 10 Highlights From BIIB’s Q3
Biogen earnings for the third quarter of 2018 are now up and "InvestorPlace' has a few highlights from the earnings report.
Gene Editing is a Major Technology to Watch
Gene-editing technology is going to be a game-changer in the future, which means the time to invest in CRISPR stocks is now.
Why Every Investor Should Hold Shares of Biogen Stock
Biogen reported solid study results for its Alzheimer's study and followed up with a solid quarterly earnings report. BIIB stock is a clear core holding for investors.
5 Top Stock Trades for Tuesday — Buy, Sell or Hold Tesla?
Micron pulled back into support, while Tesla tanked on worries over its methods for generating a profit. Here are our top stock trades for Tuesday.
Biogen Is the Right Alzheimer’s Stock … At the Wrong Time
BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist.
5 Top Stock Trades for Monday
Biogen soared 20% and gave a big lift to biotech stocks. IQiyi is finally coming back down to reasonable levels. Here are our top five stock trades for Monday.
Don’t Buy Biogen Stock on the Promise of an Alzheimer’s Breakthrough
Biogen announced that a drug that seemed to fail after 12 months had better results after 18, giving new hope for the "amyloid approach" to Alzheimer's
Biogen Inc Stock Shoots Higher on Alzheimer’s Drug Trial
Biogen (BIIB) stock was soaring today on positive results from a recent Alzheimer's drug trial conducted along with Eisai.
Biogen Inc Stock Got an Upgrade, but Should You Listen?
Analysts are buying into the recent resurgence of BIIB stock, but they may be ignoring serious fundamental headwinds. Here's a closer look at why investors should be cautious with Biogen Inc.
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.
The Good and the Bad News With Biogen Inc Earnings Results
Even before Biogen's quarterly report, BIIB stock sank after a series of disappointing clinical results. Investors have to weigh in the good and the bad developments ahead.
Here’s Why 275% in Biogen Inc Stock Looks Realistic
It’s not just as good as time as any to get long BIIB stock, it’s a better time than most using an October bull call spread.
Buy the Bottom in Biogen Inc. Stock for a 100% Return
Biogen stock is ready to rebound from a dreadful February beating. Here's how to profit from a resurgent BIIB.
This week, Biogen (BIIB) a Sell
At $286.10, Biogen (BIIB) a Sell based on the most current comparative pricing of its shares and stock market ratings.
Biogen (BIIB) a Sell This Week
At $286.95, Biogen (BIIB) a Sell based on the most recent stock market rankings, and comparative pricing of its shares.
Hold for Biogen (BIIB) This Week
At $290.01, Biogen (BIIB) a Hold based on the latest relative pricing of its shares and stock market rankings.
Hold for Biogen (BIIB) This Week
Biogen (BIIB) remains a Hold this week based on the latest relative pricing of its shares and SEC filings.
5 Biotech and Pharmaceutical Stocks Going Bonkers
These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy.
Biogen Inc Is Beckoning to the Bulls
Following pretty clean quarterly results, BIIB stock looks well-suited for a bullish trade. Here's how you can capitalize.
